Welcome to Medications.com
Depomed Reports Preliminary 2007 Year End Financial Results - Business Wire (press release)
... and a $5.0 million one-time gain from the termination of the company’s license and supply agreements with Esprit Pharma for ProQuin ® XR (ciprofloxacin ...
http://www.businesswire.com/news/... |
Posted: Thu Mar 06 16:06:26 -0500 2008
Proquin XR RSS FeedFrequently Reported Side Effects of Proquin XR
© 2002-2007, Skylabs Inc. |
About Us |
Disclaimer/Terms of Use |
Advertise |
Contact Us |
Site Map |
Developed by:
W3matter.com |
Sleep Apnea
